Proposing a new drug to treat tuberculosis utilizing state-of-the-art computer simulations
Press Releases | January 18, 2021
In silico drug design for inhibiting the cell division of Mycobacterium tuberculosis and suppressing its growth based on high-precision molecular simulations
The research team of the Department of Computer Science and Engineering at the Toyohashi University of Technology and the Institute of Food Biotechnology and Genomics at the National Academy of Sciences of Ukraine have proposed a new drug to treat tuberculosis (TB), utilizing the state-of-the-art molecular simulations. This drug may inhibit the cell division of Mycobacterium tuberculosis (M. tuberculosis) and suppress its growth. In addition, because this drug acts on the enzymes secreted by M. tuberculosis instead of acting on M. tuberculosis itself, M. tuberculosis has very little chance of mutation and develops no drug resistance. Therefore, it is expected that this drug will lead to a novel drug that will keep its effectiveness for a long time.
Full text: Proposing a new drug to treat tuberculosis utilizing state-of-the-art computer simulations
TUT website: Press release